Avni Chandrakant Shah, MD
Pediatric Endocrinology · San Francisco
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Shah’s office at (415) 476-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A83856 · Current
Licensed to practise in California · since 2003 · expires 2027-07-31 · University of Oklahoma College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Pediatrics - Pediatric Endocrinology
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 12 Part D prescriptions in 2020. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2020 | 12 | None | 0% (0) | None | $485 |
| 2014 | 27 | None | 0% (0) | None | $3,325 |
| 2013 | 30 | None | None | None | $4,004 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$17 in 2025
| 2025 | 1 | 1 | None | $17 |
| 2024 | 1 | 2 | None | $40 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Sogroya | $17 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2025-04-10 | Sogroya | $17 |
See earlier years (2024)
2024: $40
| Novo Nordisk | Sogroya | $40 | 2 payments
|
Professional record
- NPI
- 1699938928
- Licence
- CA A83856California A83856: Current · expires 2027-07-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2080P0205X (2080P0205X)
- Mailing address
- 505 Parnassus Ave, San Francisco, CA, 94143
- NPI first listed
- 2008-07-07
- NPI last updated
- 2018-03-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305